Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Fluprostenol is a metabolically stable analog of PGF2α with potent FP receptor agonist activity.1,2 Fluprostenol is the optically active enantiomer of fluprostenol and would be expected to have twice the potency as the racemic mixture. Fluprostenol inhibits PGF2α binding to human and rat FP receptors with IC50 values of 3.5 and 7.5 nM, respectively.1,2 It is a much more potent luteolytic agent than PGF2α in rats with a minimum fully effective dose of 270 µg/kg to terminate pregnancy.3 It is also an effective inhibitor of rat adipose precursor differentiation in primary cultures with an IC50 of 3-
WARNING This product is not for human or veterinary use.
1. Cloning and expression of a cDNA for the human prostanoid FP receptor. The Journal of Biological Chemisty 269(4), 2632-2636 (1994).
2. Cloning of the rat and human prostaglandin F2α receptors and the expression of the rat prostaglandin F2α receptor. FEBS Lett. 355(3), 317-325 (1994).
3. Potent luteolytic agents related to prostaglandin F2α. Nature 250(464), 330-331 (1974).
4. Prostaglandin F2α receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem. Biophys. Res. Commun. 233(1), 200-202 (1997).
Selective modulation of the prostaglandin F2a pathway markedly impacts on endometriosis progression in a xenograft mouse model. Mol. Hum. Reprod. 21(12), 905-916 (2015).